Every night on mainstream streaming platforms, I see the same rotation of charity commercials: protect dogs, save Syrian children, shelter American runaways, support childhood cancer care, preserve wildlife. Each one asks for a small monthly donation (99 cents, $5, $19), and each one insists that without your contribution, the suffering continues.

As a physician, I don’t respond to the emotional script. I respond to the ethical one. And the ethical script asks a harder question: Why are we being asked to choose at all?

Charities compete for empathy because policy has retreated

These commercials don’t exist in a vacuum. They exist because government support for families, Medicaid, immigrant services, and community mental-health programs keeps shrinking. When public systems retreat, private charities rush in, not with policy, but with marketing.

So the viewer ends up choosing between:

• American dogs
• Syrian children
• American runaways
• American children with cancer
• Endangered wildlife

That isn’t philanthropy. That’s moral triage created by advertising departments.

No citizen should have to decide whether their 99 cents goes to American dogs or Syrian children. That choice is a symptom of a system that offloads public responsibility onto private emotion.

The emotional competition between causes

The ads are engineered to bypass logic and hit the limbic system:

• A trembling dog behind a chain-link fence
• A bald child smiling bravely through chemotherapy
• A Syrian child in a tent city, eyes too old for their age
• A runaway teen curled under a blanket
• A tiger pacing through a shrinking forest

These images are powerful because they are real. And that’s exactly what makes them ethically fraught.

Dogs are innocent. Children are innocent. Runaways are vulnerable. Refugee children are traumatized. Cancer patients are suffering.

There is no morally correct choice between them. Yet the ads force one.

Charities use real patients because real patients drive donations

This is the part clinicians struggle with.

• A children’s cancer hospital: The hospital provides extraordinary care (free, comprehensive, and life-saving). But its fundraising model relies on real children, real diagnoses, real families. Consent is obtained, but compensation is not. Free care is not payment for public exposure.
• An international children’s charity: Children in conflict zones cannot meaningfully consent. Their images are used because they evoke urgency.
• A shelter for runaway youth: Runaway youth may consent, but often from vulnerable positions. Trauma can become a fundraising asset.
• An animal welfare charity: Animals cannot consent. Their suffering becomes a visual hook.
• A wildlife charity: Uses animals, not people (ethically simpler, but still part of the same emotional economy).

Clinicians are trained to protect dignity. Fundraising can do the opposite.

The hardest case: when fundraising overshadows the mission

Some organizations have drawn sharper criticism. One well-known autism charity, for example, has been criticized by families and advocates for spending too little of its donations on direct services. Its messaging historically portrayed autism as a tragedy rather than a neurodevelopmental condition. Families noticed. Clinicians noticed. Many walked away. When a charity uses children to raise money but spends little of that money on those children, trust erodes.

I’ve lived the ethical version of consent, and it looks nothing like these ads

Years ago, the family, the child, and I signed or gave assent for a photograph used in an Ohio Department of Health (ODH) pamphlet and later in the first edition of The Quiet Architect. That image didn’t exist to raise money or provoke guilt. It existed to teach, to document, to honor a system built to serve.

There’s a world of difference between representing a patient’s story with dignity and marketing their suffering for revenue. One respects the child. The other leverages the child.

Ethical visibility versus commercial exposure

Long before charity commercials became a nightly ritual, our Appalachian clinics provided free care for children with disabilities: no billing, no fundraising campaigns, no emotional manipulation. That work earned the Academic Pediatric Association’s Health Care Delivery Award and formal recognition from the surgeon general. The reward wasn’t financial; it was ethical. It proved that compassion can scale nationally without selling suffering.

Those children received care, not exposure. Their families received respect, not pity. That’s what real advocacy looks like.

The personal reflection that ties it together

I wouldn’t adopt any of the dogs in those commercials. The one I gave a forever home to was well cared for, just unwanted. Compassion doesn’t need a soundtrack. It doesn’t need a slow-motion montage. It doesn’t need a monthly subscription model.

Real care happens quietly. Marketing happens loudly. And the louder it gets, the more uneasy clinicians feel.

Where should your 99 cents go?

The honest answer is simple: One wildlife charity’s ads state that the donation does not go to the tigers, elephants, or other featured animals in the ad but to its “overall conservation efforts.” Choose the cause that aligns with your values and your lived experience.

But the larger truth is harder: You shouldn’t have to choose between American dogs and Syrian children. You shouldn’t have to choose between runaways and families losing Medicaid. Charity should supplement government responsibility, not replace it.

Until that changes, the commercials will keep coming, and clinicians will keep feeling uneasy about the way suffering is packaged for public consumption.

Ronald L. Lindsay is a retired developmental-behavioral pediatrician whose career spanned military medicine, academic leadership, and national advocacy for dignity-centered neurodevelopmental care. His NIH-funded work with the RUPP Autism Network helped define evidence-based approaches to autism and related developmental disorders.

He directed the LEND Program at The Ohio State University and founded JBLM CARES, a $10 million autism resource center for military families. His writing spans clinical scholarship and long-form fiction. He is the author of The Mercy Directive and the six-novel Cassandra series, a completed political and medical fiction saga tracing the rise of the Cassandra system from its origins to its national and international legacy. His forthcoming memoir, The Quiet Architect, examines how conscience and structure collide in modern medicine.

He shares updates on LinkedIn.